Frequency of local complications of blood transfusion and relevant risk factors among blood donor citizens of Tehran, 2005
Journal Title: Khoon - Year 2007, Vol 3, Issue 4
Abstract
Frequency of local complications of blood transfusion and relevant risk factors among blood donor citizens of Tehran, 2005 Ghafari Sh.1(MD), Majlessi F.2(MD), Rahimi Foroushani A.2(PhD), Maghsudlu M.1(MD) 1Iranian Blood Transfusion Organization-Research Center 2School of Public Health and Institute of Public Health Research, Tehran University of Medical Sciences Abstract Background and Objectives The complications of blood donation are the first reasons why donors do not return for further blood donation attempts. This study was designed to determine the frequency of these complications and their associated risk factors among blood donors in Tehran. It also aimed to provide suitable methods to decrease the frequency of adverse reactions of blood donation, thus eliminating the most important causes of nonreturn, while ensuring the health of donors. Materials and Methods This analytical descriptive cross-sectional study was performed on 554 blood donors who had donated blood from February 2004 through September 2005 in four fixed blood donation bases and four mobile blood collection buses. Each base was considered as a stratum, and a stratified random sampling proportional to size was done to select the donors. Results Reported results showed donor reaction rate of 26%, with ecchymosis (22.7%), pain (8.5%), tenderness (5.6%), and hematoma (5.1%) as the most common. The frequency of donor complications has a significant statistical correlation with manner of needle entrance in vein, lack of change in needle position under skin, prolonged phlebotomy, incomplete phlebotomy, and hard work with hand within 12 hours after donation. Conclusions Regarding the frequency values derived from different complications, it can be concluded that attention to these complications and their control can help encourage donors to become repeat donors preventing their lack of return for further blood donation. Key words: Complications, Blood donation, Risk factors SJIBTO 2007; 3(4): 317-324 Received: 5 Sep 2006 Accepted: 9 Jan 2007 Correspondence:Majlessi F., Maternal and Neonatal Health Specialist. Associate Professor, Department of Public Health Services, School of Public Health and Institute of Public Health Research, Tehran University of Medical Sciences. Tel:(+9821) 88989134; Fax: (+9821)88989129 E-mail: drfmajlessi@yahoo.com
Authors and Affiliations
Sh. Ghafari, F. Majlessi , A. Rahimi Foroushani , M. Maghsudlu
Keywords
Related Articles
- EP ID EP83738
- DOI -
- Views 94
- Downloads 0
The impact of Arsenic trioxide and thalidomide on VEGF A gene expression in AML cell lines
The impact of Arsenic trioxide and thalidomide on VEGF A gene expression in AML cell lines Mohammadi Kian M.1, Mohammadi S.2, Tavallaie M.1, Sadeghi M.1, Nikbakht M.2 1Human Genetics Research Center, Baqiyatallah Uni...
Generation of K562 cell line expressing Cas9 endonuclease (CRISPR-associated9)
Generation of K562 cell line expressing Cas9 endonuclease (CRISPR-associated9) Ansari F.1, Nikougoftar Zarif M.1, Hamidieh A.A.2, Shamsara M.3 1Blood Transfusion Research Center, High Institute for Research and Educa...
Evaluation of alternations in the expression of CCR5 chemokine receptor in acute myeloid leukemia patients with monocytic differentiation after chemotherapy
Evaluation of alternations in the expression of CCR5 chemokine receptor in acute myeloid leukemia patients with monocytic differentiation after chemotherapy Yazdani Z.1, Mousavi Z.1,2, Ghasemi-Mehr N.1, Fatemi A.1, Fa...
Gamma irradiation, an appropriate method for sterilization of the fibrin membrane while maintaining its biocompatibility characteristics
Gamma irradiation, an appropriate method for sterilization of the fibrin membrane while maintaining its biocompatibility characteristics Akbari Saied T.1, Ahmadi M.2, Fatemi A.3, Farsinejad A.R.4 1Sirjan University...
Cost-utility of treatment of the patients with Thalassemia Major in Iran
Cost-utility of treatment of the patients with Thalassemia Major in Iran Emamgholipour S.1, Ahmadi B.1, Rajabi A.2, Azarkeivan A.3,4, Ebrahimi M.3,4, Esmaeilzadeh F.5 1School of Public Health, Tehran University...